BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10732758)

  • 1. Association of CYP1A1 and microsomal epoxide hydrolase polymorphisms with lung squamous cell carcinoma.
    Lin P; Wang SL; Wang HJ; Chen KW; Lee HS; Tsai KJ; Chen CY; Lee H
    Br J Cancer; 2000 Feb; 82(4):852-7. PubMed ID: 10732758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between lung cancer and microsomal epoxide hydrolase genotypes.
    Benhamou S; Reinikainen M; Bouchardy C; Dayer P; Hirvonen A
    Cancer Res; 1998 Dec; 58(23):5291-3. PubMed ID: 9850050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
    Srivastava DS; Mandhani A; Mittal RD
    Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China.
    Yin L; Pu Y; Liu TY; Tung YH; Chen KW; Lin P
    Lung Cancer; 2001; 33(2-3):133-41. PubMed ID: 11551408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between microsomal epoxide hydrolase polymorphisms and cumulative cigarette smoking in different histological subtypes of lung cancer.
    Zhou W; Thurston SW; Liu G; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):461-6. PubMed ID: 11352855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
    Shah PP; Singh AP; Singh M; Mathur N; Pant MC; Mishra BN; Parmar D
    Mutat Res; 2008 Mar; 639(1-2):1-10. PubMed ID: 18082227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of CYP1A1 and GSTM1 and lung cancer risk.
    Gsur A; Haidinger G; Hollaus P; Herbacek I; Madersbacher S; Trieb K; Pridun N; Mohn-Staudner A; Vetter N; Vutuc C; Micksche M
    Anticancer Res; 2001; 21(3C):2237-42. PubMed ID: 11501853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between microsomal epoxide hydrolase genotypes and esophageal squamous-cell-carcinoma in Taiwan: interaction between areca chewing and smoking.
    Lin YC; Wu DC; Lee JM; Hsu HK; Kao EL; Yang CH; Wu MT
    Cancer Lett; 2006 Jun; 237(2):281-8. PubMed ID: 16029924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk for K-ras gene mutations in smoking-induced lung cancer is associated with cytochrome P4501A1 and glutathione S-transferase micro1 polymorphisms.
    Noda N; Matsuzoe D; Konno T; Kawahara K; Yamashita Y; Shirakusa T
    Oncol Rep; 2004 Oct; 12(4):773-9. PubMed ID: 15375499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
    Habalová V; Salagovic J; Kalina I; Stubna J
    Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
    Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between head and neck cancer and microsomal epoxide hydrolase genotypes.
    Wenghoefer M; Pesch B; Harth V; Broede P; Fronhoffs S; Landt O; Brüning T; Abel J; Bolt HM; Herberhold C; Vetter H; Ko YD
    Arch Toxicol; 2003 Jan; 77(1):37-41. PubMed ID: 12491039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP1A1 and GSTM1 polymorphisms in relation to lung cancer risk in Chinese women.
    Yang XR; Wacholder S; Xu Z; Dean M; Clark V; Gold B; Brown LM; Stone BJ; Fraumeni JF; Caporaso NE
    Cancer Lett; 2004 Oct; 214(2):197-204. PubMed ID: 15363546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
    Xing DY; Qi J; Tan W; Miao XP; Liang G; Yu CY; Lu WF; Zhou CN; Wu M; Lin DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Feb; 20(1):35-8. PubMed ID: 12579497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal epoxide hydrolase polymorphism and risk of spontaneous abortion.
    Wang X; Wang M; Niu T; Chen C; Xu X
    Epidemiology; 1998 Sep; 9(5):540-4. PubMed ID: 9730034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
    Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism of xenobiotic metabolising enzymes in Slovenian lung cancer patients.
    Dolzan V; Rudolf Z; Breskvar K
    Pflugers Arch; 2000; 439(3 Suppl):R29-30. PubMed ID: 10653131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.
    Raimondi S; Boffetta P; Anttila S; Bröckmoller J; Butkiewicz D; Cascorbi I; Clapper ML; Dragani TA; Garte S; Gsur A; Haidinger G; Hirvonen A; Ingelman-Sundberg M; Kalina I; Lan Q; Leoni VP; Le Marchand L; London SJ; Neri M; Povey AC; Rannug A; Reszka E; Ryberg D; Risch A; Romkes M; Ruano-Ravina A; Schoket B; Spinola M; Sugimura H; Wu X; Taioli E
    Mutat Res; 2005 Dec; 592(1-2):45-57. PubMed ID: 16009381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.